These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26519524)

  • 1. Effect of acetaminophen on sulfamethazine acetylation in male volunteers.
    Tahir IM; Iqbal T; Saleem S; Mehboob H; Akhter N; Riaz M
    Int J Immunopathol Pharmacol; 2016 Mar; 29(1):17-22. PubMed ID: 26519524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetaminophen is an inhibitor of hepatic N-acetyltransferase 2 in vitro and in vivo.
    Rothen JP; Haefeli WE; Meyer UA; Todesco L; Wenk M
    Pharmacogenetics; 1998 Dec; 8(6):553-9. PubMed ID: 9918139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.
    Hein DW; Doll MA
    Arch Toxicol; 2017 Aug; 91(8):2827-2835. PubMed ID: 28523442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats.
    Jefferson FA; Xiao GH; Hein DW
    Toxicol Sci; 2009 Jan; 107(1):293-7. PubMed ID: 18842621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylator status and N-acetyltransferase 2 gene polymorphisms; phenotype-genotype correlation with the sulfamethazine test.
    Taja-Chayeb L; González-Fierro A; Miguez-Muñoz C; Trejo-Becerril C; Cruz-Hernandez Ede L; Cantu D; Agundez JA; Vidal-Millan S; Gutierrez O; Dueñas-González A
    Pharmacogenet Genomics; 2011 Dec; 21(12):894-901. PubMed ID: 21946899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between the metabolism of procainamide and sulfamethazine.
    Giardina E-GV ; Stein RM; Bigger JT
    Circulation; 1977 Feb; 55(2):388-94. PubMed ID: 832354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetylation of the heterocyclic amine batracylin by human liver.
    Stevens GJ; Payton M; Sim E; McQueen CA
    Drug Metab Dispos; 1999 Sep; 27(9):966-71. PubMed ID: 10460792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological evidence for N-acetyltransferase isozymes in the rabbit.
    Reeves PT; Kinnear BF; Minchin RF; Ilett KF
    Mol Pharmacol; 1991 Jan; 39(1):42-8. PubMed ID: 1987451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue distribution of N-acetyltransferase 1 and 2 catalyzing the N-acetylation of 4-aminobiphenyl and O-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamster.
    Hein DW; Doll MA; Nerland DE; Fretland AJ
    Mol Carcinog; 2006 Apr; 45(4):230-8. PubMed ID: 16482518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylation phenotyping with sulfamethazine in an Iranian population.
    Sardaş S; Lahijany B; Cok I; Karakaya AE
    Pharmacogenetics; 1993 Jun; 3(3):131-4. PubMed ID: 8334437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of arylamine acetyltransferase in the rabbit eye.
    Campbell DA; Schoenwald RD; Duffel MW; Barfknecht CF
    Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2190-200. PubMed ID: 2071333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of glucose on acetylation status.
    Suhardjono D; Boutagy J; Shenfield GM
    Br J Clin Pharmacol; 1986 Oct; 22(4):401-8. PubMed ID: 3768255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine.
    Zysset T; Peretti E
    Eur J Clin Pharmacol; 1986; 30(4):463-6. PubMed ID: 3743623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Amino-3,8-dimethylimidazo-[4,5-f]quinoxaline-induced DNA adduct formation and mutagenesis in DNA repair-deficient Chinese hamster ovary cells expressing human cytochrome P4501A1 and rapid or slow acetylator N-acetyltransferase 2.
    Bendaly J; Zhao S; Neale JR; Metry KJ; Doll MA; States JC; Pierce WM; Hein DW
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1503-9. PubMed ID: 17627018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphic acetylation of the antibacterials, sulfamethazine and dapsone, in South Indian subjects.
    Peters JH; Gordon GR; Karat AB
    Am J Trop Med Hyg; 1975 Jul; 24(4):641-8. PubMed ID: 1155699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arylamine N-acetyltransferase activities in human breast cancer tissues.
    Geylan YS; Dizbay S; Güray T
    Neoplasma; 2001; 48(2):108-11. PubMed ID: 11478689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.
    Grant DM; Mörike K; Eichelbaum M; Meyer UA
    J Clin Invest; 1990 Mar; 85(3):968-72. PubMed ID: 2312737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening methods using sulfamethazine for determining acetylator phenotype.
    du Souich P; McLean AJ; Stoeckel K; Ohlendorf D; Gibaldi M
    Clin Pharmacol Ther; 1979 Dec; 26(6):757-65. PubMed ID: 498718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphic N-acetylation of sulfamethazine and benzidine by human liver: implication for cancer risk?
    Peters JH; Gordon GR; Lin E; Green CE; Tyson CA
    Anticancer Res; 1990; 10(1):225-9. PubMed ID: 2334132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N-acetylation of sulfamethazine and p-aminobenzoic acid by human liver slices in dynamic organ culture.
    Gunawardhana L; Barr J; Weir AJ; Brendel K; Sipes IG
    Drug Metab Dispos; 1991; 19(3):648-54. PubMed ID: 1680632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.